,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
271,.,.,OMIM|low_frequency,.,.,AX291,234500;138500;242600,"Hartnup disorder;Hyperglycinuria;Iminoglycinuria, digenic","1.$$$mimNumber,234500###prefix,####preferredTitle,HARTNUP DISORDER; HND###inheritance,Autosomal recessive ###growthHeight,Short stature (in some patients) ###headAndNeckMouth,Atrophic glossitis (rare) ###skinNailsHairSkin,Light-sensitive dermatitis ###neurologicCentralNervousSystem,Intermittent cerebellar ataxia ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Hypertonia ;###neurologicCentralNervousSystem,Delayed cognitive development ###neurologicPeripheralNervousSystem,Increased deep tendon reflexes ###neurologicBehavioralPsychiatricManifestations,Emotional instability ;###neurologicBehavioralPsychiatricManifestations,Psychosis ###laboratoryAbnormalities,Neutral hyperaminoaciduria ###molecularBasis,Caused by mutation in the system B(0) neutral amino acid transporter-1 gene (SLC6A19, ) 2.$$$mimNumber,242600###prefix,####preferredTitle,IMINOGLYCINURIA###inheritance,Autosomal recessive ;###inheritance,Digenic recessive ###laboratoryAbnormalities,Iminoglycinuria ;###laboratoryAbnormalities,Hydroxyprolinuria ;###laboratoryAbnormalities,Prolinuria ;###laboratoryAbnormalities,Hyperglycinuria (also present in heterozygotes) ###miscellaneous,Hyperglycinuria in heterozygotes###molecularBasis,Caused by homozygous mutations in the SLC36A2 gene () genes.",https://www.omim.org/entry/234500;https://www.omim.org/entry/138500;https://www.omim.org/entry/242600,.,Autosomal recessive;Autosomal dominant,Het,5,1216996,C,T,.,.,PASS,0/1:34:85,40.0,",,,,,,.,ttt,t,,,tTt,.T..ttT,TT,ttt.,,ttt.,T,,,t,.,...,,.Tttt,t,,,,tttt,,t,,t,t,t",missense_variant,SLC6A19,340024,.,NM_001003841.2(SLC6A19):c.1109C>T(p.Ser370Phe),NM_001003841.2,exon8(12),P0=>NP,.,.,2,0.00015,4.47e-05,0.0003,3.232e-05,0,0,2,0.00023,0,4,0.000033,.,.,http://exac.broadinstitute.org/variant/5-1216996-C-T,0.37,25.5,26,0.0,http://exac.broadinstitute.org/gene/ENSG00000174358,0.58777,0.0,0.05,D,0.544,P,0.739,P,0.003,N,1.000,N,3.0,16.82,rs376052737,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,amino acid transport (GO:0006865)|ion transport (GO:0006811)|response to nutrient (GO:0007584)|transmembrane transport (GO:0055085),brush border membrane (GO:0031526)|extracellular vesicular exosome (GO:0070062)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886),neurotransmitter:sodium symporter activity (GO:0005328)|neutral amino acid transmembrane transporter activity (GO:0015175),.,.,.,.,30,0,AX291
360,.,.,OMIM|novel,Name=LowComplexity,.,AX291,608027,"?Pontocerebellar hypoplasia, type 3","1.$$$mimNumber,608027###prefix,####preferredTitle,PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthWeight,Low weight ###headAndNeckHead,Microcephaly ;###headAndNeckHead,Brachycephaly ###headAndNeckFace,Long philtrum ;###headAndNeckFace,Full cheeks ###headAndNeckEars,Low-set ears ;###headAndNeckEars,Large ears ;###headAndNeckEars,Hearing impairment ###headAndNeckEyes,Prominent eyes ;###headAndNeckEyes,Optic atrophy ;###headAndNeckEyes,Wide palpebral fissures ###headAndNeckNose,Depressed nasal bridge ###headAndNeckMouth,High arched palate ;###headAndNeckMouth,Downturned corners of the mouth ###neurologicCentralNervousSystem,Developmental delay, severe ;###neurologicCentralNervousSystem,Neonatal hypotonia ;###neurologicCentralNervousSystem,Poor head control ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Truncal hypotonia ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Small brainstem ;###neurologicCentralNervousSystem,Small cerebellum (especially vermis) ;###neurologicCentralNervousSystem,Cerebral atrophy ;###neurologicCentralNervousSystem,Hypoplasia of the corpus callosum ###miscellaneous,Onset at birth ;###miscellaneous,Progressive disorder ;###miscellaneous,One consanguineous family has been found to carry a homozygous mutation in the PCLO gene (last curated June 2015) ###molecularBasis,Caused by mutation in the homolog of the mouse piccolo gene (PCLO, )",https://www.omim.org/entry/608027,.,Autosomal recessive,Het,7,82763559,-,TATATATATATATATATATAT,.,Name=227:(TA)n:Simple_repeat,strand fail|low coverage,0/1:6:10,60.0,.$.$.$.$.$.$.$.$.$.$.$....^].,splice_region_variant;splice_region_variant,PCLO,27445,.,NM_014510.2(PCLO):c.3300+6_3300+7insATATATATATATATATATATA;NM_033026.5(PCLO):c.3300+6_3300+7insATATATATATATATATATATA,NM_033026.5,intron3(19);intron3(24),.;.,.,.,.,.,.,.,0.0001,0,.,.,.,.,.,.,.,.,.,-4.32,117.2,11,1.0,http://exac.broadinstitute.org/gene/ENSG00000186472,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,82,1,AX291
563,.,.,HGMD|OMIM|low_frequency,.,.,AX291,114480;612555;605724;613029;155255;613347;176807;194070,"Breast cancer, male, susceptibility to;Breast-ovarian cancer, familial, 2;Fanconi anemia, complementation group D1;Glioblastoma 3;Medulloblastoma;Pancreatic cancer 2;Prostate cancer;Wilms tumor","1.$$$mimNumber,114480###prefix,####preferredTitle,BREAST CANCER###inheritance,Autosomal dominant ###neoplasia,Breast carcinoma ###miscellaneous,Genetic heterogeneity ###molecularBasis,Caused by mutation in the breast cancer type 1 gene (BRCA1, );###molecularBasis,Caused by mutation in the breast cancer type 2 gene (BRCA2, );###molecularBasis,Caused by mutation in the solute carrier family 22, member 1-like gene (SLC22A1L, );###molecularBasis,Caused by mutation in the tumor protein p53 gene (TP53, );###molecularBasis,Caused by mutation in the BRCA1-associated C-terminal helicase 1 gene (BRIP1, );###molecularBasis,Caused by mutation in the homolog of the S. cerevisiae RAD51A gene (RAD51A, );###molecularBasis,Susceptibility conferred by mutation in the homolog of the S. pombe checkpoint kinase 2 gene (CHEK2, ) 2.$$$mimNumber,612555###prefix,####preferredTitle,BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2###inheritance,Autosomal dominant ###neoplasia,Breast cancer ;###neoplasia,Ovarian cancer ###miscellaneous,Mutation carriers have an increased risk of developing breast and/or ovarian cancer at an earlier age ;###miscellaneous,Lifetime risk of breast cancer in mutation carriers is 60 to 85% ;###miscellaneous,Lifetime risk of ovarian cancer in mutation carriers is 10 to 20% ;###miscellaneous,Lifetime risk of breast cancer in male mutation carriers in 6% ;###miscellaneous,Increased risk of bilateral breast cancer ###molecularBasis,Susceptibility conferred by mutation in the breast cancer 2 gene (BRCA2, ) 3.$$$mimNumber,605724###prefix,####preferredTitle,FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthOther,Intrauterine growth retardation ;###growthOther,Failure to thrive ###headAndNeckHead,Microcephaly ###headAndNeckFace,Dysmorphic facial features, nonspecific (in some patients) ###cardiovascularHeart,Cardiac defects (in some patients) ###abdomenGastrointestinal,Imperforate anus ###skeletalHands,Hypoplastic thumbs ;###skeletalHands,Abnormal thumbs ###skinNailsHairSkin,Cafe au lait spots ###hematology,Bone marrow failure ###neoplasia,Increased susceptibility to leukemia ;###neoplasia,Increased susceptibility to solid cancers ###laboratoryAbnormalities,Multiple chromosomal breaks ;###laboratoryAbnormalities,Chromosomal breakage induced by diepoxybutane (DEB), and mitomycin C ###miscellaneous,Onset in infancy or early childhood ;###miscellaneous,Extreme sensitivity to chemotherapy ###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, ) 4.$$$mimNumber,613029###prefix,####preferredTitle,GLIOMA SUSCEPTIBILITY 3; GLM3###inheritance,Autosomal recessive ###neoplasia,Brain tumors, multiple types ;###neoplasia,Glioblastoma ;###neoplasia,Medulloblastoma ;###neoplasia,Astrocytoma ###molecularBasis,Susceptibility conferred by mutation in the BRCA2 gene (BRCA2, ) 5.$$$mimNumber,155255###prefix,####preferredTitle,MEDULLOBLASTOMA; MDB###inheritance,Somatic ;###inheritance,Autosomal dominant ;###inheritance,Autosomal recessive ###neoplasia,Medulloblastoma ###laboratoryAbnormalities,Isochromosome 17q frequent in cytogenetic studies;###laboratoryAbnormalities,Loss of heterozygosity for 17p sequences in 45% of medulloblastomas###miscellaneous,Incomplete penetrance ###molecularBasis,Caused by mutation in the suppressor of fused gene (SUFU, );###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, );###molecularBasis,Caused by somatic mutation in the catenin beta 1 gene (CTNNB1, );###molecularBasis,Caused by somatic mutation in the homolog of Drosophila patched 2 gene (PTCH2, ) 6.$$$mimNumber,194070###prefix,####preferredTitle,WILMS TUMOR 1; WT1###inheritance,Autosomal dominant ;###inheritance,Somatic mutation ###genitourinaryKidneys,Nephroblastoma ###neoplasia,Nephroblastoma ###miscellaneous,Majority of Wilms tumors are sporadic ;###miscellaneous,Onset between 2-5 years ;###miscellaneous,Rare adult cases reported ;###miscellaneous,5-10% of all Wilms tumor are bilateral ;###miscellaneous,21% of hereditary Wilms tumor are bilateral ;###miscellaneous,Associated with several congenital malformation syndromes (WAGR , abnormal urogenital development syndromes);###miscellaneous,Two-step mutation hypothesis (germline mutation followed by somatic mutation or two sequential somatic mutations) ;###miscellaneous,Loss of tumor suppressor gene ;###miscellaneous,Genetic heterogeneity ;###miscellaneous,Associated with several loci on chromosomes 11p15 (WT2, ).###molecularBasis,Caused by mutation in the WT1 gene (WT1, );###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, )",https://www.omim.org/entry/114480;https://www.omim.org/entry/612555;https://www.omim.org/entry/605724;https://www.omim.org/entry/613029;https://www.omim.org/entry/155255;https://www.omim.org/entry/613347;https://www.omim.org/entry/176807;https://www.omim.org/entry/194070,.,"Autosomal dominant;Autosomal recessive;Autosomal recessive, Autosomal dominant;Autosomal dominant, Somatic mutation",Het,13,32914277,A,G,.,.,PASS,0/1:57:106,53.77,".g$.gGggG,G.,..g,g,.g,.ggG,,GggGGGggg,.g.,gG,g.,gGg.,,gG,G,gGGG.g,g.GggGg,g.G,G,,GgGGG,G..,,,....gG..GG,,^]G^].",missense_variant,BRCA2,675,.,NM_000059.3(BRCA2):c.5785A>G(p.Ile1929Val),NM_000059.3,exon11(27),NP=>NP,0.006,0.0014,1,0.000077,0.0009,0.0100,0.0007,0.0111,0,85,0.0098,0,116,0.00096,0.016393442623,8/488,http://exac.broadinstitute.org/variant/13-32914277-A-G,-4.71,69.8,36,0.0,http://exac.broadinstitute.org/gene/ENSG00000139618,0.02095,1.16E-4,0.29,T,0.004,B,0.003,B,0.123,N,1.000,N,-5.69,0.244,rs79538375,.,.,.,.,NM_000059.3(BRCA2):c.5785A>G(p.I1929V),DM?,Breast cancer,15365993,.,.,.,.,"NM_000059.3(BRCA2):c.5782G>T(p.E1928*),DM,Breast cancer,15519522;NM_000059.3(BRCA2):c.5789delT,DM,Breast and/or ovarian cancer,18489799",37997,https://www.ncbi.nlm.nih.gov/clinvar/variation/37997,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"brain development (GO:0007420)|cell aging (GO:0007569)|centrosome duplication (GO:0051298)|cytokinesis (GO:0000910)|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)|DNA repair (GO:0006281)|double-strand break repair (GO:0006302)|double-strand break repair via homologous recombination (GO:0000724)|female gonad development (GO:0008585)|hemopoiesis (GO:0030097)|histone H3 acetylation (GO:0043966)|histone H4 acetylation (GO:0043967)|inner cell mass cell proliferation (GO:0001833)|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)|male meiosis I (GO:0007141)|negative regulation of mammary gland epithelial cell proliferation (GO:0033600)|nucleotide-excision repair (GO:0006289)|oocyte maturation (GO:0001556)|positive regulation of mitotic cell cycle (GO:0045931)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of cytokinesis (GO:0032465)|replication fork protection (GO:0048478)|response to gamma radiation (GO:0010332)|response to UV-C (GO:0010225)|response to X-ray (GO:0010165)|spermatogenesis (GO:0007283)",BRCA2-MAGE-D1 complex (GO:0033593)|centrosome (GO:0005813)|cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|protein complex (GO:0043234)|secretory granule (GO:0030141),gamma-tubulin binding (GO:0043015)|H3 histone acetyltransferase activity (GO:0010484)|H4 histone acetyltransferase activity (GO:0010485)|protease binding (GO:0002020)|single-stranded DNA binding (GO:0003697),.,.,.,.,88,2,AX291
